Clinical Trial Update: A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 trial to characterize the pharmacokinetic and pharmacodynamic profiles of epoetin alfa (PROCRIT) in anemic patients with chronic kidney disease; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Chronic Kidney Disease, Anemia | Phase 1 | Status: COMPLETED